Ionis PharmaceuticalsCarlsbad, California, United States
Disclosure information not submitted.
ORF30-04 - Prevention of Acute Pancreatitis with APOC3 Inhibition in Severe Hypertriglyceridemia Across Triglyceride Levels and Prior Pancreatitis
Sunday, June 14, 20262:00 PM - 2:15 PM CT
ORF30-07 - APOC3 Inhibition for Severe Hypertriglyceridemia in Patients with Versus without Baseline Fibrate Use
Sunday, June 14, 20262:45 PM - 3:00 PM CT